MedPath

Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars

Not Applicable
Recruiting
Conditions
Scars
Interventions
Procedure: injection of autologous nanofat grafting
Procedure: microneedling with autologus nanofat graft
Registration Number
NCT06566300
Lead Sponsor
Alexandria University
Brief Summary

This study aims to evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
    1. Males and females between 18-60 years old. 2. Post-burn or traumatic atrophic scar > 6 months duration (16). 3. Patients not receiving any treatments for the scar within the past 3 months.
Exclusion Criteria
    1. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.

    2. Diabetes and other systemic diseases that may be complicated by the procedure.

    3. Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
injection of autologous nanofat graftinginjection of autologous nanofat graftingTwo separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft.
microneedling with autologous nanofat graftmicroneedling with autologus nanofat graftTwo separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft.
Primary Outcome Measures
NameTimeMethod
change in the scar by by the patient and observer scar assessment scale (POSAS).6 months after the proceedure

patient and observer scar assessment scale score will be uesd

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alexandria University

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath